Evolution, Ayurveda, immunity, and preventive aspects for emerging infectious diseases such as COVID-19

Dhirajsingh Sumersingh Rajput (1)
(1) Department of Rasashastra and Bhaishajya Kalpana, Mahatma Gandhi Ayurved College Hospital and Research Centre, Datta Meghe University of Medical Sciences (Deemed to be University), Salod (H), Wardha, Maharashtra – 442001, India, India

Abstract

Evolution is a continuous process of changes in structural and physiological mechanism in the living being. Microbes/pathogens can evolve naturally or artificially and become resistant to various medicines. The novel corona virus is such evolved pathogen of corona virus group. Enough strong immunity is needed to prevent or survive from COVID-19 pandemic. Ayurveda provides ways for evolving physiological responses to built immunity. Present work is a brief attempt to increase insight in this filed. Present review was done based on the simple theory of evolution, recent updates regarding prevention of COVID-19, Ayurveda aspect toward infectious diseases and Ayurveda ways towards prevention of infectious diseases with special reference to COVID-19. Person with impaired immunity is more susceptible for COVID-19 and thus immunity is an important preventing factor. Ayurveda Rasayana  (rejuvenation) herbs, Yoga exercises, Pranayama  (special breathing exercise), daily regimens and personal hygiene guidelines can be helpful strategies in controlling the spread of COVID-19. The preventive aspects of pandemic situations are narrated in Ayurveda with enough details. They need to be scientifically explored and refined for precision. As prevention is always better than cure, Ayurveda ways can be considered for future strategies to avoid pandemics such as COVID-19. There is a great need for research on Ayurveda medicines on COVID-19 like diseases.

Full text article

Generated from XML file

Authors

Dhirajsingh Sumersingh Rajput
dhirajsingh.rajput@dmimsu.edu.in (Primary Contact)
Dhirajsingh Sumersingh Rajput. (2020). Evolution, Ayurveda, immunity, and preventive aspects for emerging infectious diseases such as COVID-19. International Journal of Research in Pharmaceutical Sciences, 11((SPL 1), 86–93. Retrieved from https://ijrps.com/home/article/view/1368

Article Details

Similar Articles

You may also start an advanced similarity search for this article.

No Related Submission Found